Literature DB >> 15644071

Tau protein concentrations in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

F J Jiménez-Jiménez1, A Hernánz, S Medina-Acebrón, F de Bustos, J M Zurdo, H Alonso, I Puertas, B Barcenilla, Y Sayed, F Cabrera-Valdivia.   

Abstract

OBJECTIVE: To elucidate whether cerebrospinal fluid (CSF) concentrations of the microtubule-associated tau protein are related to the risk for sporadic amyotrophic lateral sclerosis (SALS). PATIENTS/
METHODS: We measured tau concentrations in the CSF of 18 patients with SALS and 75 age- and sex-matched controls, using a specific ELISA method.
RESULTS: The mean CSF concentrations of tau protein did not differ significantly between SALS patient and control groups, were not influenced by the clinical form (spinal vs bulbar) of ALS, and were not correlated with age, age at onset, and duration of the disease.
CONCLUSIONS: CSF tau concentrations are not a biochemical marker of ALS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644071     DOI: 10.1111/j.1600-0404.2005.00370.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  13 in total

1.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

Review 2.  Use of biomarkers in ALS drug development and clinical trials.

Authors:  Nadine Bakkar; Ashley Boehringer; Robert Bowser
Journal:  Brain Res       Date:  2014-10-24       Impact factor: 3.252

3.  Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.

Authors:  Antonio Scarafino; Eustachio D'Errico; Alessandro Introna; Angela Fraddosio; Eugenio Distaso; Irene Tempesta; Antonella Morea; Antonella Mastronardi; Rosaria Leante; Maddalena Ruggieri; Mariangela Mastrapasqua; Isabella Laura Simone
Journal:  J Neurol       Date:  2018-08-16       Impact factor: 4.849

Review 4.  Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.

Authors:  Christi Kolarcik; Robert Bowser
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  CSF neurofilament protein analysis in the differential diagnosis of ALS.

Authors:  Thierry S Reijn; Wilson F Abdo; Helenius J Schelhaas; Marcel M Verbeek
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

6.  Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.

Authors:  Hiroshi Takahashi; Yasuchika Aoki; Arata Nakajima; Masato Sonobe; Fumiaki Terajima; Masahiko Saito; Takuya Miyamoto; Keita Koyama; Keiichiro Yamamoto; Takeo Furuya; Masao Koda; Seiji Ohtori; Masashi Yamazaki; Koichi Nakagawa
Journal:  Eur Spine J       Date:  2018-03-19       Impact factor: 3.134

7.  Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.

Authors:  Murray Grossman; Lauren Elman; Leo McCluskey; Corey T McMillan; Ashley Boller; John Powers; Katya Rascovsky; William Hu; Les Shaw; David J Irwin; Virginia M-Y Lee; John Q Trojanowski
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

8.  Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.

Authors:  L Fialová; J Švarcová; A Bartos; I Malbohan
Journal:  Folia Microbiol (Praha)       Date:  2012-05-08       Impact factor: 2.099

9.  Significance of CSF NfL and tau in ALS.

Authors:  Stefanie Schreiber; Nicola Spotorno; Frank Schreiber; Julio Acosta-Cabronero; Jörn Kaufmann; Judith Machts; Grazyna Debska-Vielhaber; Cornelia Garz; Daniel Bittner; Nathalie Hensiek; Reinhard Dengler; Susanne Petri; Peter J Nestor; Stefan Vielhaber
Journal:  J Neurol       Date:  2018-09-05       Impact factor: 4.849

Review 10.  Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?

Authors:  Ahmed Abdelhak; Andreas Junker; Johannes Brettschneider; Jan Kassubek; Albert C Ludolph; Markus Otto; Hayrettin Tumani
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.